ATE273307T1 - Benzo(5,6)cycloheptapyridin derivate anwendbar als farnesyl protein transferase inhibitoren - Google Patents
Benzo(5,6)cycloheptapyridin derivate anwendbar als farnesyl protein transferase inhibitorenInfo
- Publication number
- ATE273307T1 ATE273307T1 AT98932715T AT98932715T ATE273307T1 AT E273307 T1 ATE273307 T1 AT E273307T1 AT 98932715 T AT98932715 T AT 98932715T AT 98932715 T AT98932715 T AT 98932715T AT E273307 T1 ATE273307 T1 AT E273307T1
- Authority
- AT
- Austria
- Prior art keywords
- cycloheptapyridine
- benzo
- protein transferase
- transferase inhibitors
- farnesyl protein
- Prior art date
Links
- OZVMEJXYSDZMDV-UHFFFAOYSA-N 11h-benzo[1,2]cyclohepta[3,4-b]pyridine Chemical class C1=CC2=NC=CC=C2CC2=CC=CC=C21 OZVMEJXYSDZMDV-UHFFFAOYSA-N 0.000 title 1
- 239000003528 protein farnesyltransferase inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/877,366 US5939416A (en) | 1997-06-17 | 1997-06-17 | Benzo (5,6) cycloheptapyridine compounds useful as farnesyl protein transferase inhibitors |
PCT/US1998/011505 WO1998057970A1 (en) | 1997-06-17 | 1998-06-15 | Benzo(5,6)cycloheptapyridine compounds useful as farnesyl protein transferase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE273307T1 true ATE273307T1 (de) | 2004-08-15 |
Family
ID=25369837
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT98932715T ATE273307T1 (de) | 1997-06-17 | 1998-06-15 | Benzo(5,6)cycloheptapyridin derivate anwendbar als farnesyl protein transferase inhibitoren |
Country Status (12)
Country | Link |
---|---|
US (1) | US5939416A (de) |
EP (1) | EP1019400B1 (de) |
JP (1) | JP3258342B2 (de) |
CN (1) | CN1119345C (de) |
AR (1) | AR012990A1 (de) |
AT (1) | ATE273307T1 (de) |
AU (1) | AU8253398A (de) |
CA (1) | CA2293711C (de) |
DE (1) | DE69825608T2 (de) |
ES (1) | ES2221989T3 (de) |
WO (1) | WO1998057970A1 (de) |
ZA (1) | ZA985211B (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6524832B1 (en) * | 1994-02-04 | 2003-02-25 | Arch Development Corporation | DNA damaging agents in combination with tyrosine kinase inhibitors |
US6632455B2 (en) | 1997-12-22 | 2003-10-14 | Schering Corporation | Molecular dispersion composition with enhanced bioavailability |
US6271378B1 (en) | 1998-12-18 | 2001-08-07 | Schering Corporation | Process for preparing tricyclic compounds having antihistaminic activity |
US6316462B1 (en) | 1999-04-09 | 2001-11-13 | Schering Corporation | Methods of inducing cancer cell death and tumor regression |
PE20020635A1 (es) | 2000-11-29 | 2002-07-11 | Schering Corp | Compuestos triciclicos como inhibidores de la farnesil transferasa |
WO2005089518A2 (en) * | 2004-03-18 | 2005-09-29 | The Brigham And Women's Hospital, Inc. | Uch-l1 expression and cancer therapy |
WO2005089496A2 (en) * | 2004-03-18 | 2005-09-29 | The Brigham And Women's Hospital, Inc. | Methods for the treatment of synucleinopathies |
US20060194821A1 (en) * | 2005-02-18 | 2006-08-31 | The Brigham And Women's Hospital, Inc. | Compounds inhibiting the aggregation of superoxide dismutase-1 |
US20070148660A1 (en) * | 2005-06-16 | 2007-06-28 | The Regents Of The University Of California | Treatment of maladaptive substance use with H-ras antagonists |
US8232402B2 (en) | 2008-03-12 | 2012-07-31 | Link Medicine Corporation | Quinolinone farnesyl transferase inhibitors for the treatment of synucleinopathies and other indications |
EP2370436A1 (de) | 2008-11-13 | 2011-10-05 | Link Medicine Corporation | Azachinolinonderivate und deren verwendungen |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5089496A (en) * | 1986-10-31 | 1992-02-18 | Schering Corporation | Benzo[5,6]cycloheptapyridine compounds, compositions and method of treating allergies |
US5721236A (en) * | 1993-10-15 | 1998-02-24 | Schering Corporation | Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
IL111235A (en) * | 1993-10-15 | 2001-03-19 | Schering Plough Corp | Medicinal preparations for inhibiting protein G activity and for the treatment of malignant diseases, containing tricyclic compounds, some such new compounds and a process for the preparation of some of them |
US5719148A (en) * | 1993-10-15 | 1998-02-17 | Schering Corporation | Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
US5700806A (en) * | 1995-03-24 | 1997-12-23 | Schering Corporation | Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
KR20000036120A (ko) * | 1996-09-13 | 2000-06-26 | 둘락 노먼 씨. | 파르네실 단백질 트랜스퍼라제에 대한 트리사이클릭 저해제 |
CA2266014A1 (en) * | 1996-09-13 | 1998-03-19 | Schering Corporation | Tricyclic compounds useful for inhibition of farnesyl protein transferase |
-
1997
- 1997-06-17 US US08/877,366 patent/US5939416A/en not_active Expired - Fee Related
-
1998
- 1998-06-15 AT AT98932715T patent/ATE273307T1/de not_active IP Right Cessation
- 1998-06-15 CA CA002293711A patent/CA2293711C/en not_active Expired - Fee Related
- 1998-06-15 CN CN98808188A patent/CN1119345C/zh not_active Expired - Fee Related
- 1998-06-15 WO PCT/US1998/011505 patent/WO1998057970A1/en active IP Right Grant
- 1998-06-15 EP EP98932715A patent/EP1019400B1/de not_active Expired - Lifetime
- 1998-06-15 ES ES98932715T patent/ES2221989T3/es not_active Expired - Lifetime
- 1998-06-15 AU AU82533/98A patent/AU8253398A/en not_active Abandoned
- 1998-06-15 DE DE69825608T patent/DE69825608T2/de not_active Expired - Lifetime
- 1998-06-15 ZA ZA985211A patent/ZA985211B/xx unknown
- 1998-06-15 JP JP50450099A patent/JP3258342B2/ja not_active Expired - Fee Related
- 1998-06-16 AR ARP980102860A patent/AR012990A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
AU8253398A (en) | 1999-01-04 |
EP1019400A1 (de) | 2000-07-19 |
DE69825608T2 (de) | 2005-08-04 |
ES2221989T3 (es) | 2005-01-16 |
WO1998057970A1 (en) | 1998-12-23 |
CA2293711C (en) | 2004-08-24 |
DE69825608D1 (de) | 2004-09-16 |
AR012990A1 (es) | 2000-11-22 |
CA2293711A1 (en) | 1998-12-23 |
JP2000513034A (ja) | 2000-10-03 |
US5939416A (en) | 1999-08-17 |
CN1119345C (zh) | 2003-08-27 |
JP3258342B2 (ja) | 2002-02-18 |
ZA985211B (en) | 1998-12-15 |
CN1267302A (zh) | 2000-09-20 |
EP1019400B1 (de) | 2004-08-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE185341T1 (de) | 4,9-ethano-benzo(f)isoindolderivate als farnesyl transferase inhibitoren | |
ATE321757T1 (de) | (imidazol-5-yl)methyl-2-chinolinonderivate als farnesyl protein transferase inhibitoren | |
NO996571D0 (no) | Inhibitorer for farnesyl-protein-transferase | |
DE69907964D1 (de) | 1,2-annelierte chinolinderivate | |
DE69728676D1 (de) | Substituierte 6,6-heterobicyclische derivate | |
ID29311A (id) | Aturan penentuan quinolat posporibosil transferase | |
ATE435861T1 (de) | 12,13-cyclopropan-epothilonderivate | |
DE69930518D1 (de) | Als antikrebsmittel verwendbare alkinyl-substituierte chinolin-2-on-derivate | |
EE04309B1 (et) | Farnesüül-proteiini transferaasi inhibiitorid | |
EE9800408A (et) | Proteiinfarnesüültransferaasi inhibiitorid | |
ATE340176T1 (de) | Substituierte 6,5-heterobicyclische-derivate | |
PT1000048E (pt) | Derivados substituidos do 1,2,3,4-tetrahidronaftaleno | |
DE69711020D1 (de) | Thiazole derivate als protein kinase c inhibitoren | |
DE69718771T2 (de) | Substituierte 1,2,3,4-tetrahydronaphthalinderivate | |
DE69924876D1 (de) | Farnesyl protein transferase inhibitoren | |
ATE387448T1 (de) | 4,5-pyrazinoxindole als proteinkinasehemmer | |
PT921125E (pt) | Derivados de 1,38-triaza-espiro 4,5 decan-4-ona | |
ATE273307T1 (de) | Benzo(5,6)cycloheptapyridin derivate anwendbar als farnesyl protein transferase inhibitoren | |
ATE240317T1 (de) | Indolderivate als pkc-inhibitoren | |
ATE273299T1 (de) | Benzpyrido cycloheptan derivate mit farnesyl protein transferase inhibierender wirkung | |
NO20003825D0 (no) | 1,3,4 - oxadiazolonderivater | |
ATE222905T1 (de) | Benzo(5,6)cyclohepta(1,2-b)pyridine derivate als farnesyl protein transferase inhibitoren | |
DE69907254D1 (de) | 6-azauracilderivate als il-5 inhibitoren |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |